75A50325C00012
Definitive Contract
Overview
Government Description
BULK PHARMA - GROUP A (ASSET MGMT)
DOXYCYCLINE 25MG/5ML ORAL SUSPENSION, POWDER, 60ML BOTTLE, ONDANSETRON HCL 8MG, 30 TABLETS, BOTTLE
Awardee
Awarding / Funding Agency
Place of Performance
Congers, NY 10920 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Related Opportunity
None
Chartwell Rx was awarded
Definitive Contract 75A50325C00012 (75A503-25-C-00012)
worth up to $42,791,498
by the HHS Office of the Assistant Secretary for Preparedness and Response
in September 2025.
The contract
has a duration of 5 years and
was awarded
full & open
with
NAICS 325412 and
PSC 6505
via direct negotiation acquisition procedures with 1 bid received.
As of today, the Definitive Contract has a total reported backlog of $26,713,109.
Status
(Open)
Last Modified 8/27/25
Period of Performance
9/1/25
Start Date
8/31/26
Current End Date
8/31/30
Potential End Date
Obligations and Backlog
$16.1M
Total Obligated
$16.1M
Current Award
$42.8M
Potential Award
$0.0
Funded Backlog
$26.7M
Total Backlog
Award Hierarchy
Definitive Contract
75A50325C00012
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75A50325C00012
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
ER5UA9TYBGH4
Awardee CAGE
8APG0
Agency Detail
Awarding Office
75A503 ASPR/ORM-SNS
Funding Office
75A501
Created By
hhsjennifer_willis
Last Modified By
hhskgolden2
Approved By
hhskgolden2
Legislative
Legislative Mandates
None Applicable
Performance District
NY-17
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Representative
Michael Lawler
Modified: 8/27/25